Cargando…

Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA

BACKGROUND: Prostate cancer (PCa) incidences vary with genetic, geographical and ethnic dietary background of patients while angiogenesis is modulated through exquisite interplay of tumor-stromal interactions of biological macromolecules. We hypothesized that comprehensive analysis of four biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Abhijit G, Liu, Jie, Yuan, Yawei, Gopalakrishnan, Velliyur K, Johansson, Sonny L, Dinda, Amit K, Gupta, Narmada P, Trevino, Lindsey, Vishwanatha, Jamboor K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270077/
https://www.ncbi.nlm.nih.gov/pubmed/14613585
http://dx.doi.org/10.1186/1476-4598-2-34
_version_ 1782121025487503360
author Banerjee, Abhijit G
Liu, Jie
Yuan, Yawei
Gopalakrishnan, Velliyur K
Johansson, Sonny L
Dinda, Amit K
Gupta, Narmada P
Trevino, Lindsey
Vishwanatha, Jamboor K
author_facet Banerjee, Abhijit G
Liu, Jie
Yuan, Yawei
Gopalakrishnan, Velliyur K
Johansson, Sonny L
Dinda, Amit K
Gupta, Narmada P
Trevino, Lindsey
Vishwanatha, Jamboor K
author_sort Banerjee, Abhijit G
collection PubMed
description BACKGROUND: Prostate cancer (PCa) incidences vary with genetic, geographical and ethnic dietary background of patients while angiogenesis is modulated through exquisite interplay of tumor-stromal interactions of biological macromolecules. We hypothesized that comprehensive analysis of four biomarkers modulating angiogenesis in PCa progression in two diverse populations might explain the variance in the incidence rates. RESULTS: Immunohistochemical analysis of 42 PCa biopsies reveals that though Anx-II expression is lost in both the Indian and American population with Gleason scores (GS) ranging between 6 and 10, up to 25 % of cells in the entire high grade (GS > 8) PD PCa samples from US show intense focal membrane staining for Anx-II unlike similarly graded specimens from India. Consistent with this observation, the prostate cancer cell lines PC-3, DU-145 and MDA PCa 2A, but not LNCaP-R, LNCAP-UR or MDA PCa 2B cell lines, express Anx-II. Transcriptional reactivation of Anx-II gene with Aza-dC could not entirely account for loss of Anx-II protein in primary PCa. Cyclooxygenase-2 (COX-2) was moderately expressed in most of high grade PIN and some MD PCa and surrounding stroma. COX-2 was not expressed in PD PCa (GS ~7–10), while adjacent smooth muscles cells stained weakly positive. Decorin expression was observed only in high grade PIN but not in any of the prostate cancers, atrophy or BPH while stromal areas of BPH stained intensively for DCN and decreased with advancing stages of PCa. Versican expression was weak in most of the MD PCa, moderate in all of BPH, moderately focal in PD PC, weak and focal in PIN, atrophy and adjacent stroma. CONCLUSIONS: Expression of pro- and anti-angiogenic modulators changes with stage of PCa but correlates with angiogenic status. Focal membrane staining of Anx-II reappears in high grade PCa specimens only from US indicating differential expression of Anx-II. COX-2 stained stronger in American specimens compared to Indian specimens. The sequential expression of DCN and VCN in progressive stages was similar in specimens from India and USA indicating no population-based differences. The mechanistic and regulatory role of Anx-II in PCa progression warrants further investigation.
format Text
id pubmed-270077
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-2700772003-11-21 Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA Banerjee, Abhijit G Liu, Jie Yuan, Yawei Gopalakrishnan, Velliyur K Johansson, Sonny L Dinda, Amit K Gupta, Narmada P Trevino, Lindsey Vishwanatha, Jamboor K Mol Cancer Research BACKGROUND: Prostate cancer (PCa) incidences vary with genetic, geographical and ethnic dietary background of patients while angiogenesis is modulated through exquisite interplay of tumor-stromal interactions of biological macromolecules. We hypothesized that comprehensive analysis of four biomarkers modulating angiogenesis in PCa progression in two diverse populations might explain the variance in the incidence rates. RESULTS: Immunohistochemical analysis of 42 PCa biopsies reveals that though Anx-II expression is lost in both the Indian and American population with Gleason scores (GS) ranging between 6 and 10, up to 25 % of cells in the entire high grade (GS > 8) PD PCa samples from US show intense focal membrane staining for Anx-II unlike similarly graded specimens from India. Consistent with this observation, the prostate cancer cell lines PC-3, DU-145 and MDA PCa 2A, but not LNCaP-R, LNCAP-UR or MDA PCa 2B cell lines, express Anx-II. Transcriptional reactivation of Anx-II gene with Aza-dC could not entirely account for loss of Anx-II protein in primary PCa. Cyclooxygenase-2 (COX-2) was moderately expressed in most of high grade PIN and some MD PCa and surrounding stroma. COX-2 was not expressed in PD PCa (GS ~7–10), while adjacent smooth muscles cells stained weakly positive. Decorin expression was observed only in high grade PIN but not in any of the prostate cancers, atrophy or BPH while stromal areas of BPH stained intensively for DCN and decreased with advancing stages of PCa. Versican expression was weak in most of the MD PCa, moderate in all of BPH, moderately focal in PD PC, weak and focal in PIN, atrophy and adjacent stroma. CONCLUSIONS: Expression of pro- and anti-angiogenic modulators changes with stage of PCa but correlates with angiogenic status. Focal membrane staining of Anx-II reappears in high grade PCa specimens only from US indicating differential expression of Anx-II. COX-2 stained stronger in American specimens compared to Indian specimens. The sequential expression of DCN and VCN in progressive stages was similar in specimens from India and USA indicating no population-based differences. The mechanistic and regulatory role of Anx-II in PCa progression warrants further investigation. BioMed Central 2003-10-08 /pmc/articles/PMC270077/ /pubmed/14613585 http://dx.doi.org/10.1186/1476-4598-2-34 Text en Copyright © 2003 Banerjee et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research
Banerjee, Abhijit G
Liu, Jie
Yuan, Yawei
Gopalakrishnan, Velliyur K
Johansson, Sonny L
Dinda, Amit K
Gupta, Narmada P
Trevino, Lindsey
Vishwanatha, Jamboor K
Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
title Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
title_full Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
title_fullStr Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
title_full_unstemmed Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
title_short Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
title_sort expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin ii in prostate carcinomas from india and usa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC270077/
https://www.ncbi.nlm.nih.gov/pubmed/14613585
http://dx.doi.org/10.1186/1476-4598-2-34
work_keys_str_mv AT banerjeeabhijitg expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT liujie expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT yuanyawei expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT gopalakrishnanvelliyurk expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT johanssonsonnyl expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT dindaamitk expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT guptanarmadap expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT trevinolindsey expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa
AT vishwanathajamboork expressionofbiomarkersmodulatingprostatecancerangiogenesisdifferentialexpressionofannexiniiinprostatecarcinomasfromindiaandusa